A glimpse into what happens after PTCy
BLOOD（2022）
摘要
In this issue of Blood, McCurdy et al1 report findings from the first study to directly compare immune restoration after haploidentical and matched donor hematopoietic cell transplantation (HCT) using high-dose posttrans -plant cyclophosphamide (PTCy)-based graft-versus-host disease (GVHD) prophylaxis.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要